journal article Open Access Jan 01, 2023

Recent advances in nanoantibiotics against multidrug-resistant bacteria

View at Publisher Save 10.1039/d3na00530e
Abstract
In this review, we introduce recently developed nanomaterials for dealing with multidrug-resistant bacteria, and the biosafety and mass production of these nanomaterials.
Topics

No keywords indexed for this article. Browse by subject →

References
384
[1]
Carlet Lancet (2011) 10.1016/s0140-6736(11)60401-7
[2]
Nordmann Curr. Opin. Microbiol. (2007) 10.1016/j.mib.2007.07.004
[3]
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview

Elena Sánchez-López, Daniela Gomes, Gerard Esteruelas et al.

Nanomaterials 2020 10.3390/nano10020292
[4]
Molecular mechanisms of antibiotic resistance revisited

Elizabeth M. Darby, Eleftheria Trampari, Pauline Siasat et al.

Nature Reviews Microbiology 2023 10.1038/s41579-022-00820-y
[5]
Bassetti Ann. Clin. Microbiol. Antimicrob. (2013) 10.1186/1476-0711-12-22
[6]
Spellberg Clin. Infect. Dis. (2008) 10.1086/524891
[7]
Huh J. Controlled Release (2011) 10.1016/j.jconrel.2011.07.002
[8]
Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniae

Soumeya Hema‐Ouangraoua, Abdoul Aziz Maiga, Matthew Cairns et al.

Tropical Medicine & International Health 2019 10.1111/tmi.13321
[9]
Hadad Front. Microbiol. (2021) 10.3389/fmicb.2021.820998
[10]
Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates

Ken-Ichi Lee, Shu-Ichi Nakayama, Kayo Osawa et al.

Journal of Antimicrobial Chemotherapy 2019 10.1093/jac/dkz129
[11]
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus

Beata Mlynarczyk-Bonikowska, Cezary Kowalewski, Aneta Krolak-Ulinska et al.

International Journal of Molecular Sciences 2022 10.3390/ijms23158088
[12]
López-Argüello Microbiol. Spectr. (2023) 10.1128/spectrum.00692-23
[13]
Karaiskos J. Antimicrob. Chemother. (2019) 10.1093/jac/dkz015
[14]
Ida J. Clin. Microbiol. (2001) 10.1128/jcm.39.9.3115-3121.2001
[15]
Ida Antimicrob. Agents Chemother. (2002) 10.1128/aac.46.5.1516-1521.2002
[16]
Li World J. Gastroenterol. (2021) 10.3748/wjg.v27.i24.3595
[17]
Rybak Pharmacotherapy (2020) 10.1002/phar.2376
[18]
Kim Arch. Microbiol. (2020) 10.1007/s00203-020-01906-y
[19]
Quiles-Melero J. Clin. Microbiol. (2013) 10.1128/jcm.01598-12
[20]
Sjolund-Karlsson J. Clin. Microbiol. (2014) 10.1128/jcm.02679-13
[21]
Zhao Antimicrob. Resist. Infect. Control. (2020) 10.1186/s13756-020-00793-8
[22]
Gui Indian J. Microbiol. (2014) 10.1007/s12088-013-0438-4
[23]
Bojang Clin. Infect. Dis. (2018) 10.1093/cid/ciy254
[25]
Olesky J. Bacteriol. (2006) 10.1128/jb.188.7.2300-2308.2006
[26]
Chisholm Antimicrob. Agents Chemother. (2010) 10.1128/aac.00309-10
[27]
Blackadar ACS Appl. Mater. Interfaces (2022) 10.1021/acsami.2c03609
[28]
Salah BioMed Res. Int. (2022) 10.1155/2022/7380147
[29]
Luo J. Colloid Interface Sci. (2019) 10.1016/j.jcis.2018.10.041
[30]
Hodille Med. Mal. Infect. (2017) 10.1016/j.medmal.2016.10.004
[31]
Stojkovska Appl. Microbiol. Biotechnol. (2020) 10.1007/s00253-020-10521-2
[32]
Lin Biomaterials (2019) 10.1016/j.biomaterials.2019.119372
[33]
Origins and Evolution of Antibiotic Resistance

Julian Davies, Dorothy Davies

Microbiology and Molecular Biology Reviews 2010 10.1128/mmbr.00016-10
[34]
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward

Lekshmi Narendrakumar, Medha Chakraborty, Shashi Kumari et al.

Frontiers in Microbiology 2022 10.3389/fmicb.2022.1092556
[35]
Spagnolo Antimicrob. Agents Chemother. (2016) 10.1128/aac.01359-15
[36]
Tolmasky Antimicrob. Agents Chemother. (1988) 10.1128/aac.32.9.1416
[37]
Foucault Proc. Natl. Acad. Sci. U.S.A. (2010) 10.1073/pnas.1006855107
[38]
Sjölund-Karlsson J. Clin. Microbiol. (2014) 10.1128/jcm.02679-13
[39]
Rather Braz. J. Microbiol. (2021) 10.1007/s42770-021-00624-x
[40]
Huddleston Infect. Drug Resist. (2014) 10.2147/idr.s48820
[41]
Evolutionary Pathways and Trajectories in Antibiotic Resistance

F. BAQUERO, J. L. MARTINEZ, V. F. Lanza et al.

Clinical Microbiology Reviews 2021 10.1128/cmr.00050-19
[42]
Mutational background influencesP. aeruginosaciprofloxacin resistance evolution but preserves collateral sensitivity robustness

Sara Hernando-Amado, Pablo Laborda, José Ramón Valverde et al.

Proceedings of the National Academy of Sciences 2022 10.1073/pnas.2109370119
[43]
Lee Int. J. Antimicrob. Agents (2005) 10.1016/j.ijantimicag.2004.11.012
[44]
Feng Infect. Drug Resist. (2019) 10.2147/idr.s182272
[45]
Higgins Infect. Drug Resist. (2003)
[46]
Pasca Microb. Drug Resist. (2012) 10.1089/mdr.2011.0019
[47]
Bruchmann Antimicrob. Agents Chemother. (2013) 10.1128/aac.01581-12
[48]
[49]
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence

Eirini Christaki, Markella Marcou, Andreas Tofarides

Journal of Molecular Evolution 2020 10.1007/s00239-019-09914-3
[50]
Miller Expert Rev. Anti-Infect. Ther. (2014) 10.1586/14787210.2014.956092

Showing 50 of 384 references

Metrics
42
Citations
384
References
Details
Published
Jan 01, 2023
Vol/Issue
5(23)
Pages
6278-6317
License
View
Authors
Funding
National Natural Science Foundation of China Award: 22234004
Education Department of Jiangxi Province Award: GJJ2200963
Department of Science and Technology of Liaoning Province
Cite This Article
Mulan Li, Ying Liu, Youhuan Gong, et al. (2023). Recent advances in nanoantibiotics against multidrug-resistant bacteria. Nanoscale Advances, 5(23), 6278-6317. https://doi.org/10.1039/d3na00530e